Costa Rica assesses the last 20 years of its drug policies
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of ...
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of ...
The European Union's COPOLAD III programme, led by FIAP in consortium with IILA, and in partnership with EUDA and GIZ, ...
To show the progress achieved, as well as the challenges faced by the National Drug Observatories of Latin America and ...
On Thursday 25 July 2024, the National Agenda of Research Priorities in Mental Health and Addictions was launched, developed with ...
Evaluation and research on drugs is one of the priorities for making political decisions on drugs. That is why the ...
From October 23-27, 2023, the European Monitoring Centre for Drugs (EMCDDA), in the framework of COPOLAD, organized, together with the ...
What institutional, human and financial resources do the National Drug Observatories have at their disposal to consolidate their national research ...
At the end of July, 16 experts from five Latin American countries (Argentina, Bolivia, Paraguay, Uruguay and Venezuela) participated in ...
The international meeting of National Drug Observatories (NDOs) held within the framework of the emblematic EMCDDA, the European Monitoring Centre ...
The COPOLAD III Program is particularly interested in supporting the strengthening of National Drug Observatories (NDOs), both in their technical ...
COPOLAD is a consortium formed by:


Collaborating partners:


© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.